Moreover, ALKBH5 has been reported to function as a tumor promoter in AML by post-transcriptionally modulating pivotal targets, such as TACC3, an oncogene related to prognosis in a broad spectrum of carcinomas [16–19]. Here, ALKBH5 is linked to acute myeloid leukemia.